[Leish-l] Mucocutaneius leishmaniasis and lipid formulations of Amphotericin B

[Dedet Jean-Pierre: <parasito@univ-montp1.fr>]

There is a paper by :
Amato,Tuon, Campos, Bacha, Nicodemo, Amato, et al.
Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B
Clin Infect Dis., 2007, 44 : 31det1-312
Regards
J.P. De


Flavio Queiroz Telles <queiroz.telles at uol.com.br> a écrit :

>
>>
> Dear Jeffrey
>
> I am looking for some evidence about the use of the lipid formulations oaf
> Ampho B (ABELCET and AMBISOME) for the therapy of refractory or intolerant
> mucocutaneous leishmaniasis?
> Is there any published controlled clinical trial? Do you have any personal
> experience using AMBISOME or ABELCET on Mucocutaneous Leishmaniasis?
> Bets Regards
> Flavio Queiroz-Telles M
> Federal University of Parana, Brazil
>
>
>
> --
> This email was sent by icb.usp.br
>



_______________________________
Professeur Jean-Pierre Dedet
Professeur émérite et Directeur-adjoint
chargé de la gestion à la Faculté de Médecine
Université Montpellier 1
UMR MIVEGEC (CNRS 5290-IRD 224-UM1-UM2)
(Dir. D. Fontenille)

Adresse postale :
Laboratoire de Parasitologie
39, Avenue Charles Flahault
34295 MONTPELLIER CEDEX 5
FRANCE

tel. : 33 (0)4 67 33 23 50
fax :  33 (0)4 67 33 23 58
http://www.parasitologie.univ-**montp1.fr<<http://www.parasitologie.univ-
/>http://www.parasitologie.univ-
<http://montp1.fr/>montp1.fr>